Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term cooperative-oncology-group. Found 16 abstracts

Colt DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. Melanoma. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):366-400.   PMCID: not NIH funded
Tejani MA, Burtness BA. Multi-Modality Therapy for Cancer of the Esophagus and GE Junction. Current treatment options in oncology. 2012 Sep;13(3):390-402.   PMCID: Not NIH funded
Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow L, Downey RJ, Gandhi L, Ganti AK, Govindan R, Grecula JC, Hayman J, Heist RS, Horn L, Jahan TM, Koczywas M, Moran CA, Niell HB, O'Malley J, Patel JD, Ready N, Rudin CM, Williams CC. Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network. 2011 Oct;9(10):1086-113.   PMCID: not NIH funded
Cohen SJ, Zalupski MM, Modiano MR, Conkling P, Patt YZ, Davis P, Dorr RT, Boytim ML, Hersh EM. A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 2010 Jul;66(2):287-94.   PMCID: PMC2873145 [Available on 2011/1/1]
Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen CH. INITIAL RESULTS OF A PHASE I DOSE-ESCALATION TRIAL OF CONCURRENT AND MAINTENANCE ERLOTINIB AND REIRRADIATION FOR RECURRENT AND NEW PRIMARY HEAD-AND-NECK CANCER. International Journal of Radiation Oncology Biology Physics. 2010 Nov;78(4):1020-5.   PMCID: not NIH funded
Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW, Malafa MP, Muscarella P, Nakakura EK, Sasson AR, Thayer SP, Tyler DS. Pancreatic Adenocarcinoma. Journal of the National Comprehensive Cancer Network. 2010 Sep;8(9):972-+.   PMCID: PMC3135380
Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kashani-Sabet M, Lange JR, Lind A, Martin L, Martini MC, Pruitt SK, Ross MI, Sener SF, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, Weber J, Wong MK. Melanoma. Journal of the National Comprehensive Cancer Network. 2009 Mar;7(3):250-75.   PMCID: not NIH funded
Morris GJ, Millenson MM, Padavic-Shaller K, Wang H, Rogatko A, Clyde J, Boyd RL, Yeslow G, Halbherr T, Schilder RJ, Smith MR. Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphorna. Haematologica. 2004 Dec;89(12):1484-91.
Langer CJ. The emerging role of paclitaxel and carboplatin in non-small cell lung carcinoma. In: Updates in Advances in Lung Cancer. 1997. p. 73-90.
Langer CJ. Chemotherapeutic inroads in treating stage IV non-small cell lung cancer. Current Problems in Cancer. 1996 Jul;20(4):221-46.
Hudes GR, Nathan FE, Khater C, Greenberg R, Gomella L, Stern C, McAleer C. Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate-Cancer. Seminars in Oncology. 1995 Oct;22(5):41-5.
Hudes GR, Obasaju C, Chapman A, Gallo J, McAleer C, Greenberg R. Phase-I Study of Paclitaxel and Estramustine - Preliminary Activity in Hormone-Refractory Prostate-Cancer. Seminars in Oncology. 1995 Jun;22(3):6-11.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF. Paclitaxel by 24- or 1-Hour Infusion in Combination with Carboplatin in Advanced Nonsmall Cell Lung-Cancer - the Fox Chase Cancer Center Experience. Seminars in Oncology. 1995 Aug;22(4):18-29.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF. Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-Small-Cell Lung-Cancer - a Phase-Ii Toxicity, Response, and Survival Analysis. Journal of Clinical Oncology. 1995 Aug;13(8):1860-70.
Langer CJ, Leighton J, McAleer C, Comis R, Odwyer P, Ozols R. Paclitaxel and Carboplatin in the Treatment of Advanced Nonsmall Cell Lung-Cancer. Seminars in Oncology. 1995 Jun;22(3):64-9.
Borden EC, Kim K, Ryan L, Blum RH, Shiraki M, Tormey DC, Comis RL, Hahn RG, Parkinson DR. Phase-Ii Trials of Interferon-Alpha and Interferon-Beta in Advanced Sarcomas. Journal of Interferon Research. 1992 Dec;12(6):455-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term cooperative-oncology-group

cooperative-oncology-group chemotherapy phase-ii cisplatin taxol trial positron-emission-tomography carcinoma randomized trial NCCN Clinical Practice Guidelines NCCN Guidelines randomized phase-iii trial malignant-melanoma lymph-node biopsy high-risk melanoma combination chemotherapy du-145 microtubule assembly invitro radiotherapy primary cutaneous melanoma metastatic squamous-cell carcinoma vinblastine cancer therapy endoscopic retrograde infusion prospective randomized-trial dosage in-hospital mortality binds cells junction biopsy series surgical excision binding dose rate phosphate gemcitabine surgical long-term survival interferon phase-iii sentinel lymph node antitumor-activity actinomycin-d colony-stimulating factor growth-factor receptor daily thoracic radiotherapy adjuvant therapy carcinoma cell-lines high-dose interferon-alpha-2b lymph node dissection tumor xenografts early-stage melanoma american joint committee paclitaxel serum creatinine neoadjuvant chemoradiation plus cetuximab margin extended retroperitoneal lymphadenectomy resection cisplatin plus 10-deaza-aminopterin folate neuroendocrine tumors hyperfractionated radiation- preoperative chemoradiation forthcoming 7th edition prophylactic cranial irradiation ultrasonography small recombinant interleukin-2 therapy portal-vein confluence plus carboplatin pancreas esophagogastric preoperative biliary drainage cyclophosphamide concurrent chemoradiotherapy etoposide multicenter randomized-trial fluorouracil Imexon Gemcitabine-Pancreatic cancer-Phase I clinical trial adenocarcinoma combined-modality treatment chronic lymphocytic-leukemia creatinine clearance analogs cholangiopancreatography 1993 n jkl-journal of dermatologic surgery and oncology-v19-p985 metastases alpha-interferon fludarabine-low-grade NHL advanced follicular lymphoma skin adriamycin Head-and-neck cancer Recurrent antimicrotubule activity radiation therapy toxicity controlled-trials melanoma gastroesophageal junction term-follow-up progression-free survival maintenance therapy final analysis Reirradiation Erlotinib phase-ii trial antitumor efficacy pathology Multimodality therapy Esophageal carcinoma-Neoadjuvant therapy-Chemotherapy-Radiotherapy-Gastroesophageal junction (GEJ)-Esophageal cancer-Treatment suramin multiple-myeloma cell isolated limb perfusion 3-hour sponsored-working-group gemcitabine-based chemoradiation 1993 lisle l-archives of internal medicine-v153-p746 ductal carcinoma stage-iii melanoma 1-hour infusion
Last updated on Monday, July 06, 2020